Pharmaceutical Technology, January 2022 Issue

Tackling the Big Issue of Solubility

January 03, 2022

Development

46

1

Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.

Regulating Digital Therapeutics

January 02, 2022

Regulatory Watch

46

1

DTx manufacturers are taking advantage of the new regulatory flexibility, afforded by the COVID-19 pandemic, to pilot new products and generate real-world evidence to support regulatory filing and reimbursement.

Good Manufacturing Practice on Demand?

January 02, 2022

Ask the Expert

46

1

Siegfried Schmitt, vice president Technical at Parexel, discusses the difficulty of operating non-GMP and GMP quality systems in the same facility.

Major Challenges Ahead for FDA and Pharma

January 02, 2022

Regulatory Watch

46

1

To maintain smooth operations, FDA is relying on swift reauthorization of industry-paid user fee programs.

Hot Picks for 2022

January 02, 2022

From The Editor

46

1

Overall, 2021 proved to be another good year for drug approvals in Europe, albeit with a slight disappointment for Alzheimer’s patients, but what should industry be watching out for in 2022?

January Makes Your Head Spin

January 02, 2022

From The Editor

46

1

January is the kind of month that can make your head spin.

Digital Integration Platform

January 02, 2022

Product Spotlight

46

1

Scitara’s Scientific Integration Platform (SIP) establishes a flexible, adaptable framework that facilitates a fully connected laboratory.